|
|
Other links at Articles > Family Medicine |
| 4. |
Telaprevir Continues to Prove Its Potency Against HCV
|
|
|
When used with pegylated interferon alfa-2a and ribavirin, the hepatitis C virus protease inhibitor telaprevir could shorten treatment duration, according to findings from the PROVE 2 trial. Medscape Medical News
|
|
|